ArticleVaccines2024

Safety and Immunogenicity of Intranasal Razi Cov Pars as a COVID-19 Booster Vaccine in Adults: Promising Results from a Groundbreaking Clinical Trial.

Mohammad Hossein Fallah Mehrabadi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.